Discovery of MK-8831, a novel spiro-proline macrocycle as a pan-genotypic HCV-NS3/4a protease inhibitor

SF Neelamkavil, S Agrawal, T Bara… - ACS Medicinal …, 2016 - ACS Publications
We have been focused on identifying a structurally different next generation inhibitor to MK-
5172 (our Ns3/4a protease inhibitor currently under regulatory review), which would achieve …
被引用次数：31 相关文章

Discovery of MK-8831, A Novel Spiro-Proline Macrocycle as a Pan-Genotypic HCV-NS3/4a Protease Inhibitor

SF Neelamkavil, S Agrawal, T Bara… - ACS medicinal …, 2015 - pubmed.ncbi.nlm.nih.gov
We have been focused on identifying a structurally different next generation inhibitor to MK-
5172 (our Ns3/4a protease inhibitor currently under regulatory review), which would achieve …

Discovery of MK-8831, A Novel Spiro-Proline Macrocycle as a Pan-Genotypic HCV-NS3/4a Protease Inhibitor.

SF Neelamkavil, S Agrawal, T Bara… - ACS Medicinal …, 2015 - europepmc.org
Discovery of MK-8831, A Novel Spiro-Proline Macrocycle as a Pan-Genotypic HCV-NS3/4a
Protease Inhibitor. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …
[HTML] nih.gov

[HTML][HTML] Discovery of MK-8831, A Novel Spiro-Proline Macrocycle as a Pan-Genotypic HCV-NS3/4a Protease Inhibitor

SF Neelamkavil, S Agrawal, T Bara… - ACS Medicinal …, 2016 - ncbi.nlm.nih.gov
Discovery of MK-8831, A Novel Spiro-Proline Macrocycle as a Pan-Genotypic HCV-NS3/4a
Protease Inhibitor - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …